Bad Obstetric History (BOH) Advanced Panel near me in Howrah

The HSV 1, IgG & IgM test is a blood test used to measure two types of antibodies: Immunoglobulin G (IgG) and Immunoglobulin M (IgM) against herpes simplex virus (HSV) type 1. IgG antibodies indicate a past infection or long-term presence of the virus, while IgM antibodies suggest a recent or acute infection. By identifying these antibodies, this test helps determine if an individual has been exposed to the virus and distinguishes between new and existing infections.

Getting tested helps in the diagnosis and management of herpes infections. Early and precise identification of HSV infections allows timely medical intervention, reducing symptoms and preventing complications. 

The HSV 2, IgG & IgM test is a blood test used to measure two types of antibodies: Immunoglobulin G (IgG) and Immunoglobulin M (IgM) against herpes simplex virus (HSV) type 2. IgG antibodies indicate a past infection or long-term presence of the virus, while IgM antibodies suggest a recent or acute infection. By identifying these antibodies, this test helps determine if an individual has been exposed to the virus and distinguishes between new and existing infections.

Early and precise identification of HSV infections allows timely medical intervention, reducing symptoms and preventing complications. For pregnant women, detecting an HSV infection is crucial to prevent neonatal herpes, which can be severe for newborns. Additionally, knowing one's HSV status helps in taking preventive measures to avoid transmission to sexual partners and others, thus playing a significant role in public health and personal well-being.

A Cytomegalovirus IgG Antibody test measures the presence of IgG antibodies in the blood, indicating a previous CMV infection. IgG antibodies are produced several weeks after the initial CMV infection. IgG levels rise during the active infection, then stabilize as the CMV infection resolves and the virus becomes inactive. Once exposed to CMV, you will have some measurable amount of CMV IgG antibody in your blood for the rest of your life, which provides protection from getting another primary infection (immunity). However, if you have a weak immune system, the virus can reactivate and cause serious symptoms or organ damage.

A Cytomegalovirus IgM Antibody test measures the presence of Immunoglobulin M (IgM) antibodies in the blood, specifically targeting the CMV. IgM antibodies are produced by the body first in response to a CMV infection. They can be detected in the blood within a week or two after the initial exposure. IgM levels rise for a short time, then decline and usually fall below detectable levels after a few months. IgM antibody levels rise again when latent CMV is reactivated.

Elevated levels of CMV IgM antibodies indicate an ongoing infection or recent exposure to the virus. Understanding the presence of IgM antibodies helps doctors diagnose and manage CMV infections effectively. 

A Rubella Virus, IgG test measures the presence of Immunoglobulin G (IgG) antibodies specific to the rubella virus in an individual's blood. IgG antibodies are indicative of previous exposure or vaccination against rubella. This test helps assess an individual’s immunity status to the virus. If the IgG antibodies are detected, it suggests that the individual has either been vaccinated against rubella or has had a previous infection, leading to the development of immune protection. 

A Rubella Virus, IgM test determines the presence of Immunoglobulin M (IgM) antibodies in the blood against Rubella virus. IgM antibodies are the first line of defense produced by the immune system in response to a recent infection. Therefore, this test is crucial for diagnosing acute or recent rubella infections. 

In acute primary infection during pregnancy, IgM may be detected 4-15 days after the rash appears. The IgM levels begin to decline after 36 -70 days and may last up to 180 days in some cases.

A Toxoplasma gondii, IgG antibody test measures the presence of immunoglobulin G (IgG) antibodies specific to the Toxoplasma gondii parasite in the blood. These antibodies indicate a previous (past) exposure to the parasite. The presence of IgG antibodies indicates that you have had an infection, but it does not tell when. A high avidity in the IgG avidity test strongly suggests the infection happened more than 4 months ago. However, a low avidity result alone cannot be used to diagnose when the infection occurred, and further clinical evaluation is needed.

In general, having IgG antibodies to Toxoplasma gondii suggests a certain level of protection, but the effectiveness and duration of this protection can depend on factors such as the individual’s overall health, the strain of the parasite, and other immune-related considerations. 

A Toxoplasma gondii, IgM antibody test measures the presence of IgM antibodies in the blood, indicating recent or acute infection with the Toxoplasma gondii parasite. These antibodies are part of the body’s immune response and are produced when an individual is exposed to the parasite. These antibodies are the first to appear after being exposed to the parasite and may persist for up to 18 months post-infection. This test provides valuable information about recent exposure to Toxoplasma gondii, helping in the diagnosis and management of infections, especially in cases where timely detection is crucial.

The TSH (Thyroid Stimulating Hormone) Ultrasensitive test measures the levels of TSH hormone in the blood. TSH is produced by the pituitary gland located at the base of the brain. Its function is to stimulate and regulate the functioning of the thyroid gland. It signals the thyroid gland to increase or decrease the production of thyroid hormones T3 and T4 when their levels are low or high, respectively. Therefore, when the levels of T3 & T4 decrease, the pituitary gland is stimulated to release TSH. This high TSH level, in turn, stimulates the thyroid gland to release more thyroid hormones (T3 & T4). It conversely happens when the levels of thyroid hormones increase.

The Anti Cardiolipin IgG Antibody test detects specific immunoglobulins IgG antibodies, against cardiolipin, a phospholipid found in cell membranes. These antibodies can indicate autoimmune disorders such as antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE).

IgG antibodies are typically produced by the immune system later in an immune response and remain in the body for a longer time period, suggesting a more chronic or ongoing immune system activation. Therefore, the anticardiolipin IgG test is often used to diagnose chronic conditions or long-term immune responses, such as persistent blood clot formation in disorders like antiphospholipid syndrome (APS).

An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test checks for antinuclear antibodies (ANA) in your blood. These antibodies, different from typical ones that fight off invaders in the body, can attach to structures inside the body’s own cell nuclei. If ANAs are present in the blood, it may suggest that your immune system is overly sensitive, causing inflammation against your own tissues and possibly indicating autoimmune diseases. 

The Cardiolipin - IgA antibody test detects specific immunoglobulin A (IgA) antibodies against cardiolipin, a phospholipid found in cell membranes. These antibodies can indicate autoimmune disorders such as antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). IgA is not part of formal APS classification criteria but may be supportive in select cases when Immunoglobulin G (IgG) or Immunoglobulin M (IgM) are negative.

IgA antibodies are part of the immune system's mucosal defense but may also contribute to systemic autoimmune responses. Elevated IgA anticardiolipin antibodies can suggest an ongoing immune reaction, particularly in individuals who may not have detectable IgG or IgM antibodies, providing valuable diagnostic information for autoimmune and thrombotic disorders.

The Anti Cardiolipin IgM Antibody test detects specific immunoglobulins IgM antibodies against cardiolipin, a phospholipid found in cell membranes. These antibodies can indicate autoimmune disorders such as antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE).

IgM antibodies are typically the first antibodies produced by the immune system in response to an infection or antigen, and the presence of IgM antibodies in the blood sample may suggest recent or acute immune system activation. Thus, the Anti Cardiolipin IgM Antibody test is often used to diagnose acute conditions or recent immune responses, such as recent blood clot formation in disorders like antiphospholipid syndrome (APS).

The Anti Phospholipid Antibody, IgG test measures the amount of IgG antibodies that target phospholipids, which are important parts of cell membranes. High levels of these antibodies are closely related to autoimmune diseases like antiphospholipid syndrome (APS) and lupus (SLE). These antibodies can raise the risk of blood clots, such as deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, and pregnancy problems like repeated miscarriages and high blood pressure (preeclampsia). This test is crucial for diagnosing these conditions and making treatment decisions for those at risk of blood clots.

The Anti Phospholipid Antibody IgM test measures the levels of the immunoglobulin M (IgM) antibodies that bind to phospholipids, essential components of cell membranes. High levels of these antibodies can undoubtedly indicate autoimmune disorders like antiphospholipid syndrome (APS), which increase the risk of thrombotic events and pregnancy complications.Therefore, this test plays a key role in diagnosing APS and assessing the risk of future blood clots. 

The Beta 2 Glycoprotein 1 IgG Serum test detects the presence of immunoglobulin G (IgG) antibodies against Beta 2 Glycoprotein 1, a protein that plays a crucial role in regulating blood clotting. IgG indicates a chronic or ongoing immune response against β2GPI, which is often associated with an increased risk of blood clotting disorders such as those seen in APS. Elevated levels of these antibodies suggest a higher risk for thrombotic events, such as deep vein thrombosis (DVT), stroke, or miscarriage, particularly when coupled with other clinical factors. By detecting IgG antibodies, this test aids in diagnosing APS and determining the need for medical interventions to manage clotting risk, including anticoagulant therapy or closer monitoring in pregnancy.

The Beta 2 Glycoprotein 1 IgM, Serum test checks for the presence of immunoglobulin M (IgM) antibodies against Beta 2 Glycoprotein 1, a protein that helps regulate blood clotting. IgM antibodies are usually the first type of antibody the body makes in response to new infections or autoimmune issues. Elevated IgM (Immunoglobulin M) levels can indicate an ongoing or recent infection, or they can suggest an autoimmune response. In the context of pregnancy, high IgM levels might be associated with certain conditions like antiphospholipid syndrome or other immune-related issues that could affect pregnancy outcomes. When doctors notice high IgM levels, particularly in pregnant women, it can guide decisions like monitoring the pregnancy more closely for signs of complications, including preterm labor or fetal growth restrictions, considering blood thinners (like heparin or aspirin), especially if the patient is at risk of clotting disorders, which are associated with higher IgM levels in some cases and  checking for infections (e.g., TORCH infections) that could pose risks to the baby.

The Lupus Anticoagulant (LAC) Profile is a group of blood tests that help measure how lupus anticoagulant antibodies affect blood clotting. These tests include: 

1. Dilute Russell viper venom time (DRVVT) – Screen:

Measures clotting time. Prolonged clotting time suggests the presence of lupus anticoagulant.

2. Activated Partial Thromboplastin Time (APTT):

Assesses the intrinsic clotting pathway. If prolonged, it may indicate inhibitors like lupus anticoagulant.

3. Lupus Anticoagulant Test:

Confirms the presence of lupus anticoagulants (antibodies that target phospholipids and interfere with normal clotting mechanisms).